Evidence map›Paper›PMID 38527836›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Efficacy and safety of chimeric antigen receptor T-cell therapy followed by allogeneic hematopoietic stem cell transplantation in 21 patients with Ph-like acute lymphoblastic leukemia].

H P Dai, H J Shen, Z Li, W Cui, Q Y Cui, M Y Li, S F Chen, M Q Zhu, D P Wu, X W Tang

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

H P DaiThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
H J ShenThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
Z LiThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
W CuiThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
Q Y CuiThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
M Y LiThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
S F ChenThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
M Q ZhuThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
D P WuThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
X W TangThe First Affiliated Hospital of Soochow University; National Clinical Research Center for Hematologic Diseases; Jiangsu Institute of Hematology; Collaborative Innovation Center of Hematology; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou 215006, China.
Soochow University · CN

Funding

Bethune Charitable Foundation BCF-IBW-XY-20220930-13China Foundation for International Medical Exchange Z-2018-31-2102-4Frontier Clinical Technical Project of Suzhou Science and Technology plan SKY2022001National Natural Science Foundation of China 82070162Natural Science Foundation of Jiangsu Province BK20201169Suzhou diagnosis and treatment project of Clinical Key Diseases LCZX202201The Key Science Research Project of Jiangsu Commission of Health K2019022Translational Research Grant of NCRCH 2020ZKZC04
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Chimeric AntigenAcute DiseaseAdultAntigens, CD19FemaleHumansImmunotherapy, AdoptiveMaleMiddle AgedRecurrenceRetrospective StudiesYoung AdultAntigens, CD19Receptors, Chimeric AntigenAcute lymphoblastic leukemiaallogenic hematopoietic stem cell transplantationChimeric antigen T cellPh-like

Identifiers

PMID38527836
PMCPMC10951118
OpenAlexW4394751445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.